Biotech Sage
- Article Tools
- Email this Article
- Print this Article
- Rss Feed
- Del.icio.us
- Digg
- StumbleUpon
-
PLAY BEAT THE STREET GAME NOW
ImClone, Biogen and Genentech have felt pain, but opportunities could exist here.
The sector's bulls feel the same disappointment as Amgen, Praecis and Affymetrix.
The company's impressive database and the drugs it has in trial make it a firm for investors to follow.
Apple and AT&T were among the most searched stocks on TheStreet.com Friday. Here's what Cramer had to say about them recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Looking for deep value with Defiance Asset Management, polling big investors about where the market's headed, plus much more.
See who made what calls.
3 Stocks I Saw On TVDan Fitzpatrick examines three stocks viewed on Fast Money and Mad Money Today's stocks include Deere & Co., Petrobras and MBIA
TheStreet.com Ratings checks in on First Community Bancorp and First Niagara Financial Group two months after recommending the stock.
Take-Two's latest hit receives a perfect score from industry reviewers.
- Top Rocket Stocks for Week: Walter
- Cramer on Top Searched Stocks: Citi
- Credit vs. Debit Cards: Weighing the Options
- Power Stock Rankings: Energy
- Top Dividend Stocks of the Week: Pepsi
- Let the 3G-Phone War Begin
- IndyMac Sputters to Loss
- Report: Icahn Zeroes in on Yahoo!
- Tuesday's Analysts' Upgrades, Downgrades
- TSC Ratings' Upgrades, Downgrades
- Cramer's 'Mad Money' Recap: Mad Money's Rally Playbook
- The Polycarbonate Price Cut
- CalPERS Pushes for Clean House at Standard Pacific
- Investing in China: What You Need to Know
- Coming Week: 'Glimmer of Hope'
- Top Stocks With Insider Buying, Buybacks
- New Solar ETF Helps Spread Sector's Risk
- Feuerstein's Biotech-Stock Mailbag
- Need to Own Energy? Here's How to Do It
- My Company Doesn't Provide Health Insurance (Gulp!)
Sponsored by:
RSS
